Gainers

  • Vicarious Surgical RBOT shares moved upwards by 24.9% to $0.45 during Monday's after-market session. The company's market cap stands at $78.6 million. As per the news, the Q4 earnings report came out today.
  • Ekso Bionics Holdings EKSO stock increased by 21.42% to $2.55. The company's market cap stands at $45.4 million. The company's, Q4 earnings came out today.
  • Jaguar Health JAGX shares moved upwards by 20.48% to $0.17. The market value of their outstanding shares is at $8.7 million.
  • Sunshine Biopharma SBFM stock rose 11.35% to $0.05. The company's market cap stands at $2.7 million.
  • Protara Therapeutics TARA stock increased by 11.12% to $4.89. The company's market cap stands at $55.5 million.
  • Talphera TLPH shares moved upwards by 6.15% to $1.38. The company's market cap stands at $23.3 million.

Losers

  • Cara Therapeutics CARA shares decreased by 15.0% to $0.85 during Monday's after-market session. The company's market cap stands at $46.3 million. As per the news, the Q4 earnings report came out today.
  • Moleculin Biotech MBRX shares decreased by 14.25% to $0.59. The market value of their outstanding shares is at $19.7 million.
  • Tandem Diabetes Care TNDM shares decreased by 9.13% to $28.3. The market value of their outstanding shares is at $1.8 billion.
  • Ocean Biomedical OCEA stock fell 8.83% to $3.72. The company's market cap stands at $126.8 million.
  • Stereotaxis STXS stock declined by 7.67% to $2.41. The market value of their outstanding shares is at $194.9 million. As per the press release, Q4 earnings came out today.
  • Avadel Pharmaceuticals AVDL stock declined by 7.63% to $14.9. The market value of their outstanding shares is at $1.3 billion. The company's, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!